Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

FoxN1 overexpression in young mice harms immune cell and skin development.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Belimumab may cause hair loss in lupus patients.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

The skin and thymus develop similarly to protect and support immunity.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Targeting regulatory T cells may help treat age-related diseases.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.